Setting

Europe Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity

Published: 30 Sep 2022 | Report Code: 10248843 | Pages: 150

Europe single cell multiomics market was valued at $ 527.9 million in 2021 and will grow by 18.0% annually over 2021-2031, driven by the rising prevalence of chronic diseases along with the aging population, the widespread product adoption for visualization and analysis, technological advancements along with the rising R&D investment, and the significant growth in the pharmaceutical industry especially personalized medication. Highlighted with 39 tables and 77 figures, this 150-page report “Europe Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe single cell multiomics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Europe single cell multiomics market in every aspect of the classification from perspectives of Product Type, Omics Type, Application, Sample Type, Workflow, End User, and Country. Based on Product Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Instruments • Consumables • Software Based on Omics Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Single Cell Genomics (SCG) • Single Cell Transcriptomics (SCT) • Single Cell Proteomics (SCP) • Single Cell Metabolomics (SCM) By Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Clinical Research o Oncology o Cell Therapy o Immunology o Neurology o Cell Biology o Other Types of Clinical Research • Translation Research • Synthetic Biology By Sample Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Human Samples o Cancer Tissues o Stem Cells o Immune Cells o Brain Cells o Other Human Samples • Animal Samples • Microbial Samples By Workflow, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Single-Cell Isolation and Dispensing o Fluorescence-Activated Cell Sorting (FACS) o Microfluidics o Magnetic-Activated Cell Sorting (MACS) o Random Seeding o Manual Cell Picking o Laser Capture Microdissection o Other Technologies of Single-Cell Isolation and Dispensing • Single-Cell Analysis o Polymerase Chain Reaction o Next-Generation Sequencing o Mass Cytometry o Mass Spectrometry o Other Technologies of Single-Cell Analysis By End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Research and Academic Laboratories • Biopharmaceutical and Biotech Companies • Contract Research Organizations (CROs) • Other End Users Geographically, the following national/local markets are fully investigated: • Germany • UK • France • Spain • Italy • Netherlands • Rest of Europe (further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Omics Type, Workflow and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: 10x Genomics, Inc. 1CellBio, Inc. Becton, Dickinson and Company Berkeley Lights, Inc. BGI Genomics Co., Ltd. Bio-Rad Laboratories, Inc. Bio-Techne Corporation BioTuring, Inc. Danaher Corporation (Cytiva Life Sciences) Dolomite Bio Fluidigm Corporation Fluxion Biosciences Illimina, Inc Mission Bio, Inc. Namocell, Inc. NanoString Technologies, Inc. Parse Biosciences, Inc. Proteona Qiagen N.V. RareCyte, Inc. Scipio Biosciences SAS Shilps Sciences Takara Bio Inc. (Takara Holdings) Thermo Fisher Scientific Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table of Contents:
1 Introduction 8 1.1 Industry Definition and Research Scope 8 1.1.1 Industry Definition 8 1.1.2 Research Scope 9 1.2 Research Methodology 12 1.2.1 Overview of Market Research Methodology 12 1.2.2 Market Assumption 13 1.2.3 Secondary Data 13 1.2.4 Primary Data 13 1.2.5 Data Filtration and Model Design 14 1.2.6 Market Size/Share Estimation 15 1.2.7 Research Limitations 16 1.3 Executive Summary 17 2 Market Overview and Dynamics 20 2.1 Market Size and Forecast 20 2.1.1 Impact of COVID-19 on World Economy 21 2.1.2 Impact of COVID-19 on the Market 25 2.2 Major Growth Drivers 27 2.3 Market Restraints and Challenges 35 2.4 Emerging Opportunities and Market Trends 38 2.5 Porter’s Fiver Forces Analysis 42 3 Segmentation of Europe Market by Product Type 46 3.1 Market Overview by Product Type 46 3.2 Instruments 48 3.3 Consumables 49 3.4 Software 50 4 Segmentation of Europe Market by Omics Type 51 4.1 Market Overview by Omics Type 51 4.2 Single Cell Genomics (SCG) 53 4.3 Single Cell Transcriptomics (SCT) 54 4.4 Single Cell Proteomics (SCP) 55 4.5 Single Cell Metabolomics (SCM) 56 5 Segmentation of Europe Market by Application 57 5.1 Market Overview by Application 57 5.2 Clinical Research 59 5.2.1 Oncology 61 5.2.2 Cell Therapy 62 5.2.3 Immunology 63 5.2.4 Neurology 64 5.2.5 Cell Biology 65 5.2.6 Other Types of Clinical Research 66 5.3 Translation Research 67 5.4 Synthetic Biology 68 6 Segmentation of Europe Market by Sample Type 69 6.1 Market Overview by Sample Type 69 6.2 Human Samples 71 6.2.1 Cancer Tissues 73 6.2.2 Stem Cells 74 6.2.3 Immune Cells 75 6.2.4 Brain Cells 76 6.2.5 Other Human Samples 77 6.3 Animal Samples 78 6.4 Microbial Samples 79 7 Segmentation of Europe Market by Workflow 80 7.1 Market Overview by Workflow 80 7.2 Single-Cell Isolation and Dispensing 82 7.2.1 Fluorescence-Activated Cell Sorting (FACS) 84 7.2.2 Microfluidics 85 7.2.3 Magnetic-Activated Cell Sorting (MACS) 86 7.2.4 Random Seeding 87 7.2.5 Manual Cell Picking 88 7.2.6 Laser Capture Microdissection 89 7.2.7 Other Technologies of Single-Cell Isolation and Dispensing 90 7.3 Single-Cell Analysis 91 7.3.1 Polymerase Chain Reaction 93 7.3.2 Next-Generation Sequencing 94 7.3.3 Mass Cytometry 95 7.3.4 Mass Spectrometry 96 7.3.5 Other Technologies of Single-Cell Analysis 97 8 Segmentation of Europe Market by End User 98 8.1 Market Overview by End User 98 8.2 Research and Academic Laboratories 100 8.3 Biopharmaceutical and Biotech Companies 101 8.4 Contract Research Organizations (CROs) 102 8.5 Other End Users 103 9 European Market 2021-2031 by Country 104 9.1 Overview of European Market 104 9.2 Germany 107 9.3 U.K. 109 9.4 France 111 9.5 Spain 113 9.6 Italy 115 9.7 Netherlands 117 9.8 Rest of European Market 119 10 Competitive Landscape 121 10.1 Overview of Key Vendors 121 10.2 New Product Launch, Partnership, Investment, and M&A 124 10.3 Company Profiles 125 10x Genomics, Inc. 125 1CellBio, Inc. 127 Becton, Dickinson and Company 128 Berkeley Lights, Inc. 129 BGI Genomics Co., Ltd. 130 Bio-Rad Laboratories, Inc. 131 Bio-Techne Corporation 132 BioTuring, Inc. 133 Danaher Corporation (Cytiva Life Sciences) 134 Dolomite Bio 135 Fluidigm Corporation 136 Fluxion Biosciences 137 Illimina, Inc 138 Mission Bio, Inc. 139 Namocell, Inc. 140 NanoString Technologies, Inc. 141 Parse Biosciences, Inc. 142 Proteona 143 Qiagen N.V. 144 RareCyte, Inc. 145 Scipio Biosciences SAS 146 Shilps Sciences 147 Takara Bio Inc. (Takara Holdings) 148 Thermo Fisher Scientific Inc. 149 RELATED REPORTS 150
List of Tables:
Table 1. Snapshot of Europe Single Cell Multiomics Market in Balanced Perspective, 2021-2031 18 Table 2. World Economic Outlook, 2021-2031 22 Table 3. World Economic Outlook, 2021-2023 23 Table 4. Comparison of Rare Disease in Different Countries 32 Table 5. World Health Spending by Region, $ bn, 2013-2020 34 Table 6. Main Product Trends and Market Opportunities in Europe Single Cell Multiomics Market 38 Table 7. Europe Single Cell Multiomics Market by Product Type, 2021-2031, $ mn 46 Table 8. Europe Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 51 Table 9. Europe Single Cell Multiomics Market by Application, 2021-2031, $ mn 57 Table 10. Europe Single Cell Multiomics Market: Clinical Research by Type, 2021-2031, $ mn 60 Table 11. Europe Single Cell Multiomics Market by Sample Type, 2021-2031, $ mn 69 Table 12. Europe Single Cell Multiomics Market: Human Samples by Type, 2021-2031, $ mn 72 Table 13. Europe Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 80 Table 14. Europe Single Cell Multiomics Market: Single-Cell Isolation and Dispensing by Technology, 2021-2031, $ mn 83 Table 15. Europe Single Cell Multiomics Market: Single-Cell Analysis by Technology, 2021-2031, $ mn 92 Table 16. Europe Single Cell Multiomics Market by End User, 2021-2031, $ mn 98 Table 17. Europe Single Cell Multiomics Market by Country, 2021-2031, $ mn 106 Table 18. Germany Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 108 Table 19. Germany Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 108 Table 20. Germany Single Cell Multiomics Market by End User, 2021-2031, $ mn 108 Table 21. U.K. Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 110 Table 22. U.K. Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 110 Table 23. U.K. Single Cell Multiomics Market by End User, 2021-2031, $ mn 110 Table 24. France Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 112 Table 25. France Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 112 Table 26. France Single Cell Multiomics Market by End User, 2021-2031, $ mn 112 Table 27. Spain Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 114 Table 28. Spain Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 114 Table 29. Spain Single Cell Multiomics Market by End User, 2021-2031, $ mn 114 Table 30. Italy Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 116 Table 31. Italy Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 116 Table 32. Italy Single Cell Multiomics Market by End User, 2021-2031, $ mn 116 Table 33. Netherlands Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 118 Table 34. Netherlands Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 118 Table 35. Netherlands Single Cell Multiomics Market by End User, 2021-2031, $ mn 118 Table 36. Single Cell Multiomics Market in Rest of Europe by Country, 2021-2031, $ mn 120 Table 37. 10x Genomics, Inc.: Company Snapshot 125 Table 38. 10x Genomics, Inc.: Business Segmentation 126 Table 39. 10x Genomics, Inc.: Product Portfolio 126
List of Figures:
Figure 1. Research Method Flow Chart 12 Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 15 Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 17 Figure 4. Europe Single Cell Multiomics Market, 2021-2031, $ mn 20 Figure 5. Impact of COVID-19 on Business 25 Figure 6. Primary Drivers and Impact Factors of Europe Single Cell Multiomics Market 27 Figure 7. Leading Causes of Death in the World, 2000 and 2019, million 30 Figure 8. Total Reported Cases of Lyme Disease by Year in U.S., 1998-2019 31 Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 33 Figure 10. World Population 65 and Over, % of Total Population, 1950-2060 33 Figure 11. Primary Restraints and Impact Factors of Europe Single Cell Multiomics Market 35 Figure 12. Investment Opportunity Analysis 39 Figure 13. Porter’s Fiver Forces Analysis of Europe Single Cell Multiomics Market 42 Figure 14. Breakdown of Europe Single Cell Multiomics Market by Product Type, 2021-2031, % of Revenue 47 Figure 15. Europe Addressable Market Cap in 2022-2031 by Product Type, Value ($ mn) and Share (%) 47 Figure 16. Europe Single Cell Multiomics Market by Product Type: Instruments, 2021-2031, $ mn 48 Figure 17. Europe Single Cell Multiomics Market by Product Type: Consumables, 2021-2031, $ mn 49 Figure 18. Europe Single Cell Multiomics Market by Product Type: Software, 2021-2031, $ mn 50 Figure 19. Breakdown of Europe Single Cell Multiomics Market by Omics Type, 2021-2031, % of Sales Revenue 52 Figure 20. Europe Addressable Market Cap in 2022-2031 by Omics Type, Value ($ mn) and Share (%) 52 Figure 21. Europe Single Cell Multiomics Market by Omics Type: Single Cell Genomics (SCG), 2021-2031, $ mn 53 Figure 22. Europe Single Cell Multiomics Market by Omics Type: Single Cell Transcriptomics (SCT), 2021-2031, $ mn 54 Figure 23. Europe Single Cell Multiomics Market by Omics Type: Single Cell Proteomics (SCP), 2021-2031, $ mn 55 Figure 24. Europe Single Cell Multiomics Market by Omics Type: Single Cell Metabolomics (SCM), 2021-2031, $ mn 56 Figure 25. Breakdown of Europe Single Cell Multiomics Market by Application, 2021-2031, % of Sales Revenue 58 Figure 26. Europe Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%) 58 Figure 27. Europe Single Cell Multiomics Market by Application: Clinical Research, 2021-2031, $ mn 59 Figure 28. Europe Single Cell Multiomics Market by Clinical Research: Oncology, 2021-2031, $ mn 61 Figure 29. Europe Single Cell Multiomics Market by Clinical Research: Cell Therapy, 2021-2031, $ mn 62 Figure 30. Europe Single Cell Multiomics Market by Clinical Research: Immunology, 2021-2031, $ mn 63 Figure 31. Europe Single Cell Multiomics Market by Clinical Research: Neurology, 2021-2031, $ mn 64 Figure 32. Europe Single Cell Multiomics Market by Clinical Research: Cell Biology, 2021-2031, $ mn 65 Figure 33. Europe Single Cell Multiomics Market by Clinical Research: Other Types of Clinical Research, 2021-2031, $ mn 66 Figure 34. Europe Single Cell Multiomics Market by Application: Translation Research, 2021-2031, $ mn 67 Figure 35. Europe Single Cell Multiomics Market by Application: Synthetic Biology, 2021-2031, $ mn 68 Figure 36. Breakdown of Europe Single Cell Multiomics Market by Sample Type, 2021-2031, % of Revenue 70 Figure 37. Europe Addressable Market Cap in 2022-2031 by Sample Type, Value ($ mn) and Share (%) 70 Figure 38. Europe Single Cell Multiomics Market by Sample Type: Human Samples, 2021-2031, $ mn 71 Figure 39. Europe Single Cell Multiomics Market by Human Samples: Cancer Tissues, 2021-2031, $ mn 73 Figure 40. Europe Single Cell Multiomics Market by Human Samples: Stem Cells, 2021-2031, $ mn 74 Figure 41. Europe Single Cell Multiomics Market by Human Samples: Immune Cells, 2021-2031, $ mn 75 Figure 42. Europe Single Cell Multiomics Market by Human Samples: Brain Cells, 2021-2031, $ mn 76 Figure 43. Europe Single Cell Multiomics Market by Human Samples: Other Human Samples, 2021-2031, $ mn 77 Figure 44. Europe Single Cell Multiomics Market by Sample Type: Animal Samples, 2021-2031, $ mn 78 Figure 45. Europe Single Cell Multiomics Market by Sample Type: Microbial Samples, 2021-2031, $ mn 79 Figure 46. Breakdown of Europe Single Cell Multiomics Market by Workflow, 2021-2031, % of Revenue 81 Figure 47. Europe Addressable Market Cap in 2022-2031 by Workflow, Value ($ mn) and Share (%) 81 Figure 48. Europe Single Cell Multiomics Market by Workflow: Single-Cell Isolation and Dispensing, 2021-2031, $ mn 82 Figure 49. Europe Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Fluorescence-Activated Cell Sorting (FACS), 2021-2031, $ mn 84 Figure 50. Europe Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Microfluidics, 2021-2031, $ mn 85 Figure 51. Europe Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Magnetic-Activated Cell Sorting (MACS), 2021-2031, $ mn 86 Figure 52. Europe Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Random Seeding, 2021-2031, $ mn 87 Figure 53. Europe Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Manual Cell Picking, 2021-2031, $ mn 88 Figure 54. Europe Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Laser Capture Microdissection, 2021-2031, $ mn 89 Figure 55. Europe Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Other Technologies of Single-Cell Isolation and Dispensing, 2021-2031, $ mn 90 Figure 56. Europe Single Cell Multiomics Market by Workflow: Single-Cell Analysis, 2021-2031, $ mn 91 Figure 57. Europe Single Cell Multiomics Market by Single-Cell Analysis: Polymerase Chain Reaction, 2021-2031, $ mn 93 Figure 58. Europe Single Cell Multiomics Market by Single-Cell Analysis: Next-Generation Sequencing, 2021-2031, $ mn 94 Figure 59. Europe Single Cell Multiomics Market by Single-Cell Analysis: Mass Cytometry, 2021-2031, $ mn 95 Figure 60. Europe Single Cell Multiomics Market by Single-Cell Analysis: Mass Spectrometry, 2021-2031, $ mn 96 Figure 61. Europe Single Cell Multiomics Market by Single-Cell Analysis: Other Technologies of Single-Cell Analysis, 2021-2031, $ mn 97 Figure 62. Breakdown of Europe Single Cell Multiomics Market by End User, 2021-2031, % of Revenue 98 Figure 63. Europe Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 99 Figure 64. Europe Single Cell Multiomics Market by End User: Research and Academic Laboratories, 2021-2031, $ mn 100 Figure 65. Europe Single Cell Multiomics Market by End User: Biopharmaceutical and Biotech Companies, 2021-2031, $ mn 101 Figure 66. Europe Single Cell Multiomics Market by End User: Contract Research Organizations (CROs), 2021-2031, $ mn 102 Figure 67. Europe Single Cell Multiomics Market by End User: Other End Users, 2021-2031, $ mn 103 Figure 68. Breakdown of European Single Cell Multiomics Market by Country, 2021 and 2031, % of Revenue 105 Figure 69. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 106 Figure 70. Single Cell Multiomics Market in Germany, 2021-2031, $ mn 107 Figure 71. Single Cell Multiomics Market in U.K., 2021-2031, $ mn 109 Figure 72. Single Cell Multiomics Market in France, 2021-2031, $ mn 111 Figure 73. Single Cell Multiomics Market in Spain, 2021-2031, $ mn 113 Figure 74. Single Cell Multiomics Market in Italy, 2021-2031, $ mn 115 Figure 75. Single Cell Multiomics Market in Netherlands, 2021-2031, $ mn 117 Figure 76. Single Cell Multiomics Market in Rest of Europe, 2021-2031, $ mn 119 Figure 77. Growth Stage of Europe Single Cell Multiomics Industry over the Forecast Period 121
Selected Key Players: 
10x Genomics, Inc.
1CellBio, Inc.
Becton, Dickinson and Company
Berkeley Lights, Inc.
BGI Genomics Co., Ltd.
Bio-Rad Laboratories, Inc.
Bio-Techne Corporation
BioTuring, Inc.
Danaher Corporation (Cytiva Life Sciences)
Dolomite Bio
Fluidigm Corporation
Fluxion Biosciences
Illimina, Inc
Mission Bio, Inc.
Namocell, Inc.
NanoString Technologies, Inc.
Parse Biosciences, Inc.
Proteona
Qiagen N.V.
RareCyte, Inc.
Scipio Biosciences SAS
Shilps Sciences
Takara Bio Inc. (Takara Holdings)
Thermo Fisher Scientific Inc. 
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)